GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Cash Ratio

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Cash Ratio : 1.35 (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Oxford Cannabinoid Technologies Holdings's Cash Ratio for the quarter that ended in Oct. 2023 was 1.35.

Oxford Cannabinoid Technologies Holdings has a Cash Ratio of 1.35. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Oxford Cannabinoid Technologies Holdings's Cash Ratio or its related term are showing as below:

FRA:0CB' s Cash Ratio Range Over the Past 10 Years
Min: 0.45   Med: 3.9   Max: 20.93
Current: 1.35

During the past 5 years, Oxford Cannabinoid Technologies Holdings's highest Cash Ratio was 20.93. The lowest was 0.45. And the median was 3.90.

FRA:0CB's Cash Ratio is ranked worse than
67.67% of 1525 companies
in the Biotechnology industry
Industry Median: 2.85 vs FRA:0CB: 1.35

Oxford Cannabinoid Technologies Holdings Cash Ratio Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Cash Ratio Chart

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Cash Ratio
0.02 3.02 0.45 15.39 3.94

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Cash Ratio Get a 7-Day Free Trial Premium Member Only 15.39 20.92 3.86 3.94 1.35

Competitive Comparison of Oxford Cannabinoid Technologies Holdings's Cash Ratio

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Cannabinoid Technologies Holdings's Cash Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's Cash Ratio falls into.



Oxford Cannabinoid Technologies Holdings Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Oxford Cannabinoid Technologies Holdings's Cash Ratio for the fiscal year that ended in Apr. 2023 is calculated as:

Cash Ratio (A: Apr. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=2.609/0.663
=3.94

Oxford Cannabinoid Technologies Holdings's Cash Ratio for the quarter that ended in Oct. 2023 is calculated as:

Cash Ratio (Q: Oct. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1.308/0.969
=1.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Cannabinoid Technologies Holdings  (FRA:0CB) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Oxford Cannabinoid Technologies Holdings Cash Ratio Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines